Janus Henderson Group
KRYS icon

Janus Henderson Group’s Krystal Biotech KRYS Stock Holding History

Janus Henderson Group’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$68.9M Buy
266,659
+47,219
+22% +$12.6M 0.03% 347
2025
Q4 		$54.1M Buy
219,440
+209,369
+2,079% +$44.1M 0.02% 397
2025
Q3 		$1.78M Hold
10,071
– – ﹤0.01% 1384
2025
Q2 		$1.38M Hold
10,071
– – ﹤0.01% 1459
2025
Q1 		$1.85M Hold
10,071
– – ﹤0.01% 1320
2024
Q4 		$1.58M Buy
10,071
+1,400
+16% +$248K ﹤0.01% 1437
2024
Q3 		$1.58M Hold
8,671
– – ﹤0.01% 1426
2024
Q2 		$1.59M Sell
8,671
-125
-1% -$21K ﹤0.01% 1364
2024
Q1 		$1.57M Hold
8,796
– – ﹤0.01% 1400
2023
Q4 		$1.09M Sell
8,796
-12
-0.1% -$1.33K ﹤0.01% 1581
2023
Q3 		$1.02M Buy
8,808
+14
+0.2% +$1.71K ﹤0.01% 1548
2023
Q2 		$1.03M Sell
8,794
-17
-0.2% -$1.74K ﹤0.01% 1602
2023
Q1 		$706K Buy
8,811
+4,287
+95% +$337K ﹤0.01% 1824
2022
Q4 		$358K Buy
+4,524
New +$336K ﹤0.01% 1892
2022
Q2 		– Sell
-4,304
Closed -$286K – 2639
2022
Q1 		$286K Buy
4,304
+1,395
+48% +$87.1K ﹤0.01% 2251
2021
Q4 		$204K Buy
+2,909
New +$169K ﹤0.01% 2385

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Janus Henderson Group's KRYS Position: Q1 2026 in Review

Janus Henderson Group increased its Krystal Biotech (KRYS) stake by 22% in Q1 2026, buying an estimated $12.6M and bringing the position to 266,659 shares worth $68.9M. The position accounts for 0.03% of the portfolio, ranked #347.

Janus Henderson Group first reported a position in KRYS in Q4 2021 and has held it in 16 quarters since. 368 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Janus Henderson Group held 266,659 shares of Krystal Biotech worth $68.9M as of Q1 2026.
  • Janus Henderson Group bought 47,219 Krystal Biotech shares in Q1 2026, an estimated $12.6M.
  • Krystal Biotech made up 0.03% of Janus Henderson Group's portfolio in Q1 2026, its #347 holding.
  • Janus Henderson Group first reported a position in Krystal Biotech in Q4 2021 and has held it in 16 quarters since.
  • 368 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.